pharma imports

Indian pharmaceutical stocks experienced a downturn following Donald Trump's renewed threat to impose tariffs on pharmaceutical imports. The Nifty Pharma index fell by 1.7%, with major companies like Gland Pharma and Sun Pharma seeing significant declines. Trump's statement highlighted the intention to incentivize pharmaceutical companies to shift production to the US through tariffs, impacting India's substantial generic drug exports to the US.

Indian pharma companies brace for potential US tariffs that could raise drug prices, disrupt supply chains, and reduce competitiveness. Analysts suggest tariffs may peak at 10% on Indian medicines, affecting major exporters like Sun Pharma and Dr. Reddy’s. The industry, crucial for US generics supply, faces risks of margin compression and export slowdowns.

The Trump administration's decision to exempt tariffs on Indian pharma imports brings relief to a $9 billion-plus US export market, highlighting India's key role in providing affordable generic medicines. However, India's medical device sector faces a 26% reciprocal tariff, potentially impacting its growth and exports.

Stock market today: BSE Sensex and Nifty50, the Indian equity benchmark indices, closed in red on Wednesday taking cues from global markets. While BSE Sensex went below 73,700 intraday, Nifty50 dipped to near 22,350 levels.

A Russian missile struck a warehouse belonging to Kusum Healthcare, an Indian pharmaceutical company, in Ukraine, prompting condemnation from the Ukrainian embassy, which alleged a deliberate targeting of Indian businesses. While details on damage and casualties remain scarce, the incident has yet to elicit comment from the Indian or Russian governments.

The US has exempted Indian pharmaceuticals from tariffs amidst President Trump’s broad tariff imposition, recognizing their crucial role in global healthcare. This move reinforces India’s position as a key provider of affordable generic medicines. Leaders highlight the strategic importance of the bilateral trade relationship, with the exemption offering India a chance to enhance its pharmaceutical sector.

Hetero Group founder, B Parthasaradhi Reddy, warns of potential US reciprocal tariffs on Indian pharmaceuticals, which could disrupt India's pharma industry, leading to higher prices and reduced market share. He urges the Indian government to consider negotiations or a free trade agreement to avoid this crisis.

The sector needs to clean up its act and focus on quality. It won’t until the Indian government insists on more and better regulations

Indian stock market indices, BSE Sensex and Nifty50, suffered significant declines on Friday, triggered by US recession fears and new tariffs announced by American President Donald Trump.

Indian stocks with significant US market exposure are facing heavy selling pressure amid growing recession fears in the US and a potential global slowdown. Concerns over high US import tariffs and retaliatory measures are impacting sectors like auto, metals, software, and pharma.

Prioritizing holistic nutrition across all ages is crucial for overall well-being, especially with modern lifestyle challenges. Men benefit from protein-rich diets and Ayurvedic herbs like Ashwagandha for stamina and hormonal balance. Women need iron, calcium, and marine collagen for hormonal support and bone health, while children require Omega-3s and Lutein for brain, vision, and immune system development.

Art Garfunkel, age 83, disclosed his long-hidden struggle with psoriasis and the profound impact of finding effective treatment through biologic medication. Supported by his family, he now works to raise awareness about the condition, while continuing to pursue his musical passion.